ICMR main Balram Bhargava now said just 2 to 4 at 10,000 breakthrough illnesses, i.e. Covid diseases post-inoculation, are seen in India so much, which has been minimal and not painful. ICMR data shows slight infections following the initial and also the next dosages of india-made COVAXIN and Covishield.